Send Enquiry

CURE
Tablets
Packaging and packing Type
Alu Alu | 10x10
MRP :
₹106
PTR :
₹80.76
PTS :
₹72.69
Prescription medicine Read More
Composition
Send Enquiry
Available on PCD franchise with monopoly rights: Cardiac and diabetic PCD franchise
India’s Trusted Pharma Brand
100%
Genuine Products
Secure
Payments
24 x 7
Customer Support
About the product
By Vibcare Pharma · Updated 9 October 2026 · Based on product labels and standard drug references
Voglivib 0.2 is a tablet for oral use. Each tablet contains Voglibose 0.2 mg, and it belongs to the alpha-glucosidase inhibitor class of anti-diabetic medicines. It is packed as 10x10 (Alu Alu) and is available from Vibcare Pharma.
The active ingredient Voglibose acts in the small intestine. It slows down the enzymes that break down carbohydrates from food into sugar, so the sugar from a meal is absorbed at a slower and more even rate. This helps to soften the rise in blood sugar that normally happens after eating.
These tablets are meant for use in adults with type 2 diabetes mellitus, as an add-on to diet and exercise. Use only on a doctor's prescription.
Use only on a doctor's prescription, at the dose and for the duration advised.
Common
Get medical help at once if you notice
Do not use
Ask a doctor first
For distributors and medical representatives
Voglivib 0.2 Tablet is part of Vibcare Pharma's cardiac and diabetic range. Take the range to your area as a PCD franchise partner, with monopoly rights in your district.
Cardiac and diabetic PCD franchisePCD pharma franchise with Vibcare
Voglivib 0.2 tablets contain voglibose 0.2 mg and are used to control blood sugar in type 2 diabetes. Main uses: used along with diet and exercise in type 2 diabetes mellitus; helps control blood sugar levels after meals; reduces post-meal rise in blood glucose; used as an add-on when diet and exercise alone do not give enough control.
Common side effects of Voglivib 0.2 Tablet include flatulence (gas); abdominal distension or bloating; loose motions (diarrhoea); stomach pain or discomfort; nausea; constipation. Get medical help at once if you notice severe stomach pain with vomiting (possible ileus or bowel obstruction); yellowing of eyes or skin, or liver-related symptoms; severe allergic reaction with swelling or difficulty breathing.
Each Voglivib 0.2 tablet contains Voglibose 0.2 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Voglivib 0.2 Tablet only as your doctor advises.
The MRP of Voglivib 0.2 Tablet is ₹106 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹80.76 and the PTS is ₹72.69.
Each Voglivib 0.2 tablet contains Voglibose 0.2 mg. It comes in a pack of 10x10 (Alu Alu).
The active ingredient Voglibose acts in the small intestine. It slows down the enzymes that break down carbohydrates from food into sugar, so the sugar from a meal is absorbed at a slower and more even rate. This helps to soften the rise in blood sugar that normally happens after eating.
Must not be used by patients allergic to voglibose. Must not be used in severe infection, diabetic ketoacidosis or diabetic precoma. Must not be used in type 1 diabetes. Must not be used before or after surgery, or after serious trauma. Check with a doctor first if you have liver or kidney problems, bowel disease, a history of abdominal surgery, or are pregnant or breastfeeding, and if you also take insulin or a sulfonylurea, as low blood sugar may occur.
Voglivib 0.2 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.
Similar Products
Send Enquiry
Request a callback to get more information about becoming a PCD Franchise Owner